You are about leaving the Roche Diagram website now.


Growing Our Understanding of the Global Impact of Alzheimer’s Disease

Alzheimer’s disease is the most common form of dementia.2 What is Alzheimer’s Disease, and how can it affect people?

Alzheimers Desktop 3 - Inside the Lab
Alzheimers Desktop 4 - Inside the Lab
Alzheimers Desktop 5 - Inside the Lab
Alzheimers Desktop 6 - Inside the Lab
Alzheimers Mobile - Inside the Lab


  1. The Alzheimer’s Society. Types of dementia.[2019 Aug 9]. Available from:
  2. World Health Organization. Dementia. [2019 Aug 20]. Available from:
  3. All Forum. Alzheimer’s disease research timeline. [2019 Aug9]. Available from:
  4. The Alzheimer’s Society. Normal ageing vs dementia. [2019 Aug 9]. Available from:
  5. National Institute on Aging. What happens to the brain in Alzheimer’s disease? [2019 aug 9]. Available from :
  6. National Institute on Aging. What causes Alzheimer’s disease. [2019 Aug 9]. Available from: whatcauses-alzheimers-disease.
  7. Alzheimer’s Research UK. Alzheimer’s disease. [2019 Aug 27]. Available from:
  8. Alzheimer’s Association. 2019 Alzheimer’s disease facts and figures. Alzheimer’s Dement. 2019:15(3):321-87.
  9. Alzheimer’s Europe. Familial Alzheimer’s disease. [Internet: cited Aug 9]. Available from:
  10. Ballard C, et al. Alzheimer’s disease. Lancet. 2011;377:1019-31.
  11. Alzheimer’s Association. 10 Early Signs and Symptoms of Alzheimer’s. [2019 Aug 9]. Available from:
  12. Alzheimer’s Research UK. Symptoms. [2019 Aug 9]. Available from:
  13. NHS. Alzheimer’s disease – diagnosis. [2019 Aug 9]. Available from:
  14. Alzheimer’s Disease Internation. 2018 dementia statistics. [2019, July 30]. Available from:
  15. Zverova M. Alzheimer’s disease and bloodbased biomarkers – potential contexts of use. Neuropsychiatr Dis Treat. 2018;14:1877-1882.
  16. Alzheimer’s Association. Earlier Diagnosis. [2019, July 30]. Available from:
  17. Mayeux R. Biomarkers: Potential Uses and Limitations. NeuroRx. 2004;1[2]: 182-188.
  18. El-Hayek YH, Wiley RE, et al. Tip of the iceberg: assessing the global socioeconomic costs of Alzheimer’s disease and related dementias and strategic implecations for stakeholders. J Alzheimer’s Dis. 2019:70:321-339.

*The information contained in this article was extracted from Edition 2022, Vol 12.

Read this volume online

You May Also Like

21 October 2022

Early Diagnosis is Key to Tackle the Growing Alzheimer’s Crisis

Every three seconds, someone around the world develops Alzheimer’s Disease or a Related Dementia (ADRD)

Read More
17 September 2021

A Fresh, Bold Approach for Alzheimer’s Diagnosis

No nation will escape a spike in dementia numbers. But with regional cases potentially tripling by 2050, APAC in particular must gear up to fight the impact of dementia.

Read More